Skip to content

Usage and Health Effects of Embodied Conversational Agents among Older Adults

Usage and Health Effects of Embodied Conversational Agents among Older Adults - PACO Evaluation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON49823
Enrollment
60
Registered
2020-07-03
Start date
2020-08-28
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Loneliness and eating behaviour

Interventions

The application PACO has been created for (and with) older adults with the goal to motivate them to increase their eating behavior and decrease their feelings of loneliness.

Sponsors

Wageningen Universiteit
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Living indipendently at home; without partner; no paid profession; 65+; Dutch speaking; able to use a tablet or computer

Exclusion criteria

Exclusion criteria: Not willing to provide inform consent

Design outcomes

Primary

MeasureTime frame
The main study parameters are based on the conceptual models, and include actual use (operationalized via logfiles), loneliness, and eating behavior.

Secondary

MeasureTime frame
The secondary parameters are based on the conceptual models, and include enjoyment (pleasure in using the application), aesthetics (the design of the application in terms of e.g. *duidelijk* and *prettig*), privacy concerns (about sharing personal data, e.g. name and date of birth), control (control over the system, as perceived by the user), usability (whether PACO is easy to use), perceived usefulness (e.g., in terms of *nuttig* and *geschikt*), relationship with ECA (e.g., in terms of *betrouwbaar*, *menselijk* and *sympathiek*), Quality of Life (QoL), and the self-determination constructs (autonomy, competence, relatedness).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)